Journal article
The Middle East respiratory syndrome--how worried should we be?
mBio, Vol.4(4), e00531-13
08/20/2013
DOI: 10.1128/mBio.00531-13
PMCID: PMC3747588
PMID: 23963179
Abstract
Ten years after the severe acute respiratory syndrome epidemic, a second coronavirus, the Middle East respiratory syndrome coronavirus (MERS-CoV), has been identified as the cause of a highly lethal pneumonia in patients in the Middle East and in travelers from this region. Over the past 9 months, since the virus was first isolated, much has been learned about the biology of the virus. It is now clear that MERS-CoV is transmissible from person to person, and its close relationship with several bat coronaviruses suggests that these animals may be the ultimate source of the infection. However, many key issues need to be addressed, including identification of the proximate, presumably zoonotic, source of the infection, the prevalence of the infection in human populations, details regarding clinical and pathological features of the human infection, the establishment of a small rodent model for the infection, and the virological and immune basis for the severe disease observed in most patients. Most importantly, we do not know whether a MERS-CoV epidemic is likely or not. Infection with the virus has so far resulted in only 91 cases and 46 deaths (as of 29 July 2013), but it is nonetheless setting off alarm bells among public health officials, including Margaret Chan, Director-General of the World Health Organization, who called MERS-CoV "a threat to the entire world." This article reviews some of the progress that has been made and discusses some of the questions that need to be answered.
Details
- Title: Subtitle
- The Middle East respiratory syndrome--how worried should we be?
- Creators
- Stanley Perlman - Department of Microbiology, University of Iowa, Iowa City, Iowa, USA. Stanley-perlman@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- mBio, Vol.4(4), e00531-13
- DOI
- 10.1128/mBio.00531-13
- PMID
- 23963179
- PMCID
- PMC3747588
- NLM abbreviation
- mBio
- ISSN
- 2161-2129
- eISSN
- 2150-7511
- Publisher
- United States
- Grant note
- AI091322 / NIAID NIH HHS R01 AI091322 / NIAID NIH HHS P01 AI060699 / NIAID NIH HHS AI060699 / NIAID NIH HHS
- Language
- English
- Date published
- 08/20/2013
- Academic Unit
- Microbiology and Immunology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9983777351202771
Metrics
16 Record Views